{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:04:30Z","timestamp":1788217470076,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2012.211","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T15:03:17Z","timestamp":1359644597000},"page":"e478-e478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK\/ATM activation and diminished cell cycle arrest"],"prefix":"10.1038","volume":"4","author":[{"given":"L","family":"Lundholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"H\u00e5\u00e5g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Juntti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"M\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lewensohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Viktorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"BFcddis2012211_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12094-011-0656-3","volume":"13","author":"R Perona","year":"2011","unstructured":"Perona R, Lopez-Ayllon BD, de Castro Carpeno J, Belda-Iniesta C . A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. Clin Transl Oncol 2011; 13: 289\u2013293.","journal-title":"Clin Transl Oncol"},{"key":"BFcddis2012211_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.lungcan.2010.08.022","volume":"71","author":"A Chang","year":"2011","unstructured":"Chang A . Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 2011; 71: 3\u201310.","journal-title":"Lung Cancer"},{"key":"BFcddis2012211_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11523-010-0132-y","volume":"5","author":"L Toschi","year":"2010","unstructured":"Toschi L, Cappuzzo F . Impact of biomarkers on non-small cell lung cancer treatment. Target Oncol 2010; 5: 5\u201317.","journal-title":"Target Oncol"},{"key":"BFcddis2012211_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1155\/2008\/396281","volume":"24","author":"SR Pine","year":"2008","unstructured":"Pine SR, Marshall B, Varticovski L . Lung cancer stem cells. Dis Markers 2008; 24: 257\u2013266.","journal-title":"Dis Markers"},{"key":"BFcddis2012211_CR5","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.1073\/pnas.0905653106","volume":"106","author":"G Bertolini","year":"2009","unstructured":"Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 2009; 106: 16281\u201316286.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2012211_CR6","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","volume":"67","author":"MM Ho","year":"2007","unstructured":"Ho MM, Ng AV, Lam S, Hung JY . Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827\u20134833.","journal-title":"Cancer Res"},{"key":"BFcddis2012211_CR7","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/cncr.25599","volume":"117","author":"HS Hsu","year":"2011","unstructured":"Hsu HS, Lin JH, Huang WC, Hsu TW, Su K, Chiou SH et al. Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer 2011; 117: 1516\u20131528.","journal-title":"Cancer"},{"key":"BFcddis2012211_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2008","unstructured":"Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504\u2013514.","journal-title":"Cell Death Differ"},{"key":"BFcddis2012211_CR9","doi-asserted-by":"publisher","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","volume":"3","author":"YC Chen","year":"2008","unstructured":"Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 2008; 3: e2637.","journal-title":"PLoS One"},{"key":"BFcddis2012211_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1089\/scd.2008.0338","volume":"18","author":"Y Wu","year":"2009","unstructured":"Wu Y, Wu PY . CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 2009; 18: 1127\u20131134.","journal-title":"Stem Cells Dev"},{"key":"BFcddis2012211_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756\u2013760.","journal-title":"Nature"},{"key":"BFcddis2012211_CR12","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1523\/JNEUROSCI.1634-10.2010","volume":"30","author":"S Facchino","year":"2010","unstructured":"Facchino S, Abdouh M, Chatoo W, Bernier G . BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci 2010; 30: 10096\u201310111.","journal-title":"J Neurosci"},{"key":"BFcddis2012211_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1073\/pnas.0606599104","volume":"104","author":"WA Woodward","year":"2007","unstructured":"Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM . WNT\/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 2007; 104: 618\u2013623.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2012211_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semradonc.2008.11.003","volume":"19","author":"WA Woodward","year":"2009","unstructured":"Woodward WA, Bristow RG . Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology). Semin Radiat Oncol 2009; 19: 87\u201395.","journal-title":"Semin Radiat Oncol"},{"key":"BFcddis2012211_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1124\/mol.109.063172","volume":"77","author":"SB Howell","year":"2010","unstructured":"Howell SB, Safaei R, Larson CA, Sailor MJ . Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol 2010; 77: 887\u2013894.","journal-title":"Mol Pharmacol"},{"key":"BFcddis2012211_CR16","doi-asserted-by":"publisher","first-page":"pii: 396076","DOI":"10.1155\/2011\/396076","volume":"2011","author":"N Moore","year":"2011","unstructured":"Moore N, Lyle S . Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol 2011; 2011: pii: 396076.","journal-title":"J Oncol"},{"key":"BFcddis2012211_CR17","first-page":"862879","volume":"2012","author":"S Tanida","year":"2012","unstructured":"Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Kamiya T, Kataoka H et al. Mechanisms of cisplatin-induced apoptosis and of cisplatin sensitivity: potential of bin1 to act as a potent predictor of cisplatin sensitivity in gastric cancer treatment. Int J Surg Oncol 2012; 2012: 862879.","journal-title":"Int J Surg Oncol"},{"key":"BFcddis2012211_CR18","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1093\/nar\/gks270","volume":"40","author":"L Krejci","year":"2012","unstructured":"Krejci L, Altmannova V, Spirek M, Zhao X . Homologous recombination and its regulation. Nucleic Acids Res 2012; 40: 5795\u20135818.","journal-title":"Nucleic Acids Res"},{"key":"BFcddis2012211_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1158\/0008-5472.CAN-11-3070","volume":"72","author":"Y Li","year":"2012","unstructured":"Li Y, Laterra J . Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res 2012; 72: 576\u2013580.","journal-title":"Cancer Res"},{"key":"BFcddis2012211_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10555-010-9216-5","volume":"29","author":"JP Sullivan","year":"2010","unstructured":"Sullivan JP, Minna JD, Shay JW . Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev 2010; 29: 61\u201372.","journal-title":"Cancer Metastasis Rev"},{"key":"BFcddis2012211_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1158\/1541-7786.MCR-08-0393","volume":"7","author":"F Jiang","year":"2009","unstructured":"Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330\u2013338.","journal-title":"Mol Cancer Res"},{"key":"BFcddis2012211_CR22","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1349-7006.2009.01144.x","volume":"100","author":"X Meng","year":"2009","unstructured":"Meng X, Li M, Wang X, Wang Y, Ma D . Both CD133+ and CD133\u2212 subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci 2009; 100: 1040\u20131046.","journal-title":"Cancer Sci"},{"key":"BFcddis2012211_CR23","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","volume":"70","author":"SH Chiou","year":"2010","unstructured":"Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial\u2013mesenchymal transdifferentiation. Cancer Res 2010; 70: 10433\u201310444.","journal-title":"Cancer Res"},{"key":"BFcddis2012211_CR24","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1002\/cncr.25869","volume":"117","author":"HS Hsu","year":"2011","unstructured":"Hsu HS, Huang PI, Chang YL, Tzao C, Chen YW, Shih HC et al. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer 2011; 117: 2970\u20132985.","journal-title":"Cancer"},{"key":"BFcddis2012211_CR25","doi-asserted-by":"crossref","unstructured":"Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD et al. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 5: e14062.","DOI":"10.1371\/journal.pone.0014062"},{"key":"BFcddis2012211_CR26","doi-asserted-by":"publisher","first-page":"941876","DOI":"10.1155\/2011\/941876","volume":"2011","author":"R Morrison","year":"2011","unstructured":"Morrison R, Schleicher SM, Sun Y, Niermann KJ, Kim S, Spratt DE et al. Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol 2011; 2011: 941876.","journal-title":"J Oncol"},{"key":"BFcddis2012211_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2011.10.012","volume":"315","author":"LS Piao","year":"2012","unstructured":"Piao LS, Hur W, Kim TK, Hong SW, Kim SW, Choi JE et al. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett 2012; 315: 129\u2013137.","journal-title":"Cancer Lett"},{"key":"BFcddis2012211_CR28","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/jnci\/djj495","volume":"98","author":"TM Phillips","year":"2006","unstructured":"Phillips TM, McBride WH, Pajonk F . The response of CD24(\u2212\/low)\/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006; 98: 1777\u20131785.","journal-title":"J Natl Cancer Inst"},{"key":"BFcddis2012211_CR29","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/cr040704h","volume":"106","author":"AR Timerbaev","year":"2006","unstructured":"Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK . Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology. Chem Rev 2006; 106: 2224\u20132248.","journal-title":"Chem Rev"},{"key":"BFcddis2012211_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/1541-7786.MCR-09-0030","volume":"7","author":"G Frosina","year":"2009","unstructured":"Frosina G . DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res 2009; 7: 989\u2013999.","journal-title":"Mol Cancer Res"},{"key":"BFcddis2012211_CR31","doi-asserted-by":"publisher","first-page":"11594","DOI":"10.1158\/0008-5472.CAN-06-4138","volume":"66","author":"DE White","year":"2006","unstructured":"White DE, Negorev D, Peng H, Ivanov AV, Maul GG, Rauscher FJ . KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions. Cancer Res 2006; 66: 11594\u201311599.","journal-title":"Cancer Res"},{"key":"BFcddis2012211_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB . DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421: 499\u2013506.","journal-title":"Nature"},{"key":"BFcddis2012211_CR33","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2004-11-4516","volume":"106","author":"B Austen","year":"2005","unstructured":"Austen B, Powell JE, Alvi A, Edwards I, Hooper L, Starczynski J et al. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. Blood 2005; 106: 3175\u20133182.","journal-title":"Blood"},{"key":"BFcddis2012211_CR34","first-page":"ra32","volume":"3","author":"X Li","year":"2010","unstructured":"Li X, Lin HH, Chen H, Xu X, Shih HM, Ann DK . SUMOylation of the transcriptional co-repressor KAP1 is regulated by the serine and threonine phosphatase PP1es. Sci Signal 2010; 3: ra32.","journal-title":"Sci Signal"},{"key":"BFcddis2012211_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1073\/pnas.1018696108","volume":"108","author":"X Yan","year":"2011","unstructured":"Yan X, Ma L, Yi D, Yoon JG, Diercks A, Foltz G et al. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci USA 2011; 108: 1591\u20131596.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2012211_CR36","first-page":"133","volume":"93","author":"J Bergh","year":"1985","unstructured":"Bergh J, Nilsson K, Ekman R, Giovanella B . Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand A 1985; 93: 133\u2013147.","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"key":"BFcddis2012211_CR37","first-page":"1011","volume":"2","author":"G Abate","year":"1998","unstructured":"Abate G, Mshana RN, Miorner H . Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1998; 2: 1011\u20131016.","journal-title":"Int J Tuberc Lung Dis"},{"key":"BFcddis2012211_CR38","doi-asserted-by":"crossref","unstructured":"Darzynkiewicz Z, Huang X . Analysis of cellular DNA content by flow cytometry. Curr Protoc Immunol 2004; Chapter 5 (Unit 5.7).","DOI":"10.1002\/0471142735.im0507s60"},{"key":"BFcddis2012211_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1525-1438.2006.00304.x","volume":"16","author":"D Gallo","year":"2006","unstructured":"Gallo D, Fruscella E, Ferlini C, Apollonio P, Mancuso S, Scambia G . Preclinical in vivo activity of a combination gemcitabine\/liposomal doxorubicin against cisplatin-resistant human ovarian cancer (A2780\/CDDP). Int J Gynecol Cancer 2006; 16: 222\u2013230.","journal-title":"Int J Gynecol Cancer"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis2012211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis2012211","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2012211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:56:01Z","timestamp":1672962961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2012211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1]]}},"alternative-id":["BFcddis2012211"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2012.211","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]},"assertion":[{"value":"19 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}